InvestorsHub Logo
Followers 0
Posts 273
Boards Moderated 0
Alias Born 03/04/2005

Re: None

Tuesday, 05/10/2005 1:26:23 PM

Tuesday, May 10, 2005 1:26:23 PM

Post# of 173880
DYNT $1.75. PROFITABLE. EARNINGS tomorrow 5/11

DYNT will release its quarterly report on 5/11 before the market opens...


+++++ INVESTMENT HIGHLIGHTS ++++++

* DYNT IS A CONSISTENTLY PROFITABLE MEDICAL DEVICE COMPANY. PROFITABLE EVERY QUARTER!!

* UNDERVALUED. TRADING AT 0.7 P/S COMPARED TO INDUSTRY AVERAGE OF 3.4. MARKET CAP IS ONLY $15 MILLION.

* SOLID BALANCE SHEET WITH NO LONG-TERM DEBT.

* ONLY 7 MILLION SHARES IN THE FLOAT.

* MANY NEW PRODUCTS IN THE PIPELINE TO BE LAUNCHED THIS SUMMER.

* NEW PRODUCTS WILL INCREASE REVENUES BY AT LEAST 20% ACCORDING TO COMPANY.

* DURING THE LAST Q CC, DYNT's CEO SAID THAT TERRELL OWENS USED DYNATRONICS' FDA-APPROVED LIGHT THERAPY DURING HIS INTESIVE REHAB TO GET HIM WELL/READY FOR THE SUPERBOWL!!!.


The most interesting item I've heard during the last Quarter CC was that Terrell Owens was treated with Dynatronics Solaris FDA-approved Light Therapy for pain treatment, arthritis, osteoarthritis, and carpal syndrome.

Light therapy is a non-invasive, no side effect arthritis treatment. Right after last quarter, DYNT's light thereapy gainED a lot of visibility as a result of the adverse publicity received by competitors VIOXX and Celebrex.

To get the word out about the benefits of light therapy over VIOXX/Celebrex/other medications, they have renowned pain-management experts holding seminars around the country to educate patients suffering of pain, arthritis, carpal syndrome of the benefits on the non-intrusive, no-side-effect light therapy by Dynatronics.

Another significant comment made by the CEO is that he expects revenues to increase by at least 20% after the release of new products this summer. New products usually mean higher gross margins and higher net income.

The company received CE certification in Europe (equivalent to the FDA in the US) to market its light therapy products.


ADOUT DYNT:

Dynatronics (Nasdaq: DYNT) manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www dynatronics com.





Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.